 | Up a level |
2021
Besse, Benjamin, Drilon, Alexander E., Solomon, Benjamin J., Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, Lin, Aimee K., French, Pearl Plernjit, Goto, Koichi and Gautschi, Oliver (2021). Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion plus non-small cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Drilon, Alexander E., Gautschi, Oliver, Besse, Benjamin, Subbiah, Vivek, Tan, Daniel Shao-Weng, Park, Keunchil, De Braud, Filippo G., Alonso, Guzman, Wolf, Juergen, Soldatenkova, Victoria, French, Pearl Plernjit, Lin, Aimee K., Goto, Koichi and Solomon, Benjamin J. (2021). Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC). J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
2020
Solomon, Benjamin J., Loong, Herbert H. F., Summers, Yvonne J., Thomas, Zachary M., French, Pearl Plernjit, Lin, Boris K., Sashegyi, Andreas, Wolf, Juergen, Yang, James Chih-Hsin and Drilon, Alexander E. (2020). Correlation between overall response rate and progression-free survival/overall survival in comparative trials involving targeted therapies in molecularly enriched populations. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755